Skip to main content

Kura Oncology, Inc.

KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422143

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Kura Oncology, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
141
+8 vs. Q3 2023
Shares held
78.8M
+3.43M (+4.6%) vs. Q3 2023
Total value
$1.13B
+$445.6M (+64.9%) vs. Q3 2023
New holders
23
48 more added
Sold out
15
44 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 141 institutions
Q1 2021: 171 institutionsQ2 2021: 171 institutionsQ3 2021: 152 institutionsQ4 2021: 151 institutionsQ1 2022: 152 institutionsQ2 2022: 148 institutionsQ3 2022: 148 institutionsQ4 2022: 142 institutionsQ1 2023: 141 institutionsQ2 2023: 148 institutionsQ3 2023: 133 institutionsQ4 2023: 141 institutionsQ1 2024: 165 institutionsQ2 2024: 174 institutionsQ3 2024: 179 institutionsQ4 2024: 185 institutionsQ1 2025: 183 institutionsQ2 2025: 182 institutionsQ3 2025: 200 institutionsQ4 2025: 215 institutionsQ1 2026: 222 institutionsQ2 2026: 221 institutions
Value heldQ4 2023: $1.13B
Q1 2021: $1.94BQ2 2021: $1.41BQ3 2021: $1.25BQ4 2021: $897.8MQ1 2022: $1.06BQ2 2022: $1.26BQ3 2022: $977.5MQ4 2022: $870.3MQ1 2023: $885.3MQ2 2023: $795.1MQ3 2023: $686.9MQ4 2023: $1.13BQ1 2024: $1.72BQ2 2024: $1.66BQ3 2024: $1.61BQ4 2024: $686.3MQ1 2025: $530.9MQ2 2025: $473.6MQ3 2025: $742.6MQ4 2025: $888.2MQ1 2026: $686.5MQ2 2026: $953.1M
Institutions holding KURA and their total value by quarter
QuarterHoldersValue
Q2 2026221$953.1M
Q1 2026222$686.5M
Q4 2025215$888.2M
Q3 2025200$742.6M
Q2 2025182$473.6M
Q1 2025183$530.9M
Q4 2024185$686.3M
Q3 2024179$1.61B
Q2 2024174$1.66B
Q1 2024165$1.72B
Q4 2023141$1.13B
Q3 2023133$686.9M
Q2 2023148$795.1M
Q1 2023141$885.3M
Q4 2022142$870.3M
Q3 2022148$977.5M
Q2 2022148$1.26B
Q1 2022152$1.06B
Q4 2021151$897.8M
Q3 2021152$1.25B
Q2 2021171$1.41B
Q1 2021171$1.94B

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Kura Oncology, Inc.; share changes are against Q3 2023.

Institutions holding KURA in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
D. E. Shaw & Co., Inc.205,620$2.96M0.00%−1,480−0.7%Reduced
Barclays PLC207,272$2.98M0.00%+52,027+33.5%Added
Russell Investments Group, Ltd.224,784$3.23M0.01%+28,817+14.7%Added
Bank of New York Mellon Corp260,789$3.75M0.00%−955−0.4%Reduced
Renaissance Technologies LLC278,100$4.00M0.01%+162,500+140.6%Added
Algert Global LLC333,450$4.80M0.19%−31,574−8.6%Reduced
Alethea Capital Management, LLC350,445$5.04M5.81%00.0%Unchanged
Deutsche Bank AG354,279$5.09M0.00%+322,591+1,018.0%Added
Verition Fund Management LLC465,593$6.70M0.07%+465,593New
JPMorgan Chase & Co472,992$6.80M0.00%−8,877−1.8%Reduced
DAFNA Capital Management LLC492,684$7.08M1.70%−58,100−10.5%Reduced
Goldman Sachs Group Inc531,562$7.64M0.00%+70,765+15.4%Added
Candriam Luxembourg S.C.A.541,417$7.79M0.05%−150,005−21.7%Reduced
Charles Schwab Investment Management Inc579,987$8.34M0.00%+16,566+2.9%Added
Acuta Capital Partners, LLC701,349$10.1M5.68%−744−0.1%Reduced
Sphera Funds Management Ltd.703,287$10.1M1.88%00.0%Unchanged
Northern Trust Corp709,820$10.2M0.00%+4,442+0.6%Added
Bank of America Corp751,341$10.8M0.00%+580,885+340.8%Added
Prosight Management, LP950,000$13.7M5.48%−982,456−50.8%Reduced
Citadel Advisors LLC1,120,572$16.1M0.02%−351,720−23.9%Reduced
Assenagon Asset Management S.A.1,153,845$16.6M0.05%00.0%Unchanged
Commodore Capital LP1,248,062$17.9M1.57%−151,938−10.9%Reduced
Paradigm Biocapital Advisors LP1,262,828$18.2M0.85%+50,000+4.1%Added
Morgan Stanley1,330,955$19.1M0.00%+1,169,992+726.9%Added
Franklin Resources Inc1,353,665$19.5M0.01%+130,710+10.7%Added
TCG Crossover Management, LLC1,423,642$20.5M2.27%00.0%Unchanged
Geode Capital Management, LLC1,656,009$23.8M0.00%+78,053+4.9%Added
Sofinnova Investments, Inc.1,667,321$24.0M1.34%+1,667,321New
Artal Group S.A.1,768,056$25.4M0.87%−250,000−12.4%Reduced
Foresite Capital Management IV, LLC1,849,947$26.6M13.44%00.0%Unchanged
Dimensional Fund Advisors LP2,001,754$28.8M0.01%+197,530+10.9%Added
Armistice Capital, LLC2,224,000$32.0M0.85%−12,000−0.5%Reduced
Holocene Advisors, LP2,437,463$35.1M0.14%00.0%Unchanged
State Street Corp2,921,810$42.0M0.00%−334,777−10.3%Reduced
Avoro Capital Advisors LLC2,980,000$42.9M0.59%00.0%Unchanged
Vanguard Group Inc4,037,691$58.1M0.00%+113,243+2.9%Added
Deerfield Management Company, L.P. (Series C)5,312,733$76.4M1.41%+938,689+21.5%Added
EcoR1 Capital, LLC5,806,871$83.5M2.17%00.0%Unchanged
Suvretta Capital Management, LLC6,946,230$99.9M4.57%−389,615−5.3%Reduced
BlackRock Inc.7,315,647$105.2M0.00%+394,602+5.7%Added
BVF Inc7,373,228$106.0M2.65%+642,245+9.5%Added
Dark Forest Capital Management LP0$00.00%−80,162−100.0%Sold out
Jump Financial, LLC0$00.00%−49,614−100.0%Sold out
Thrivent Financial for Lutherans0$00.00%−39,465−100.0%Sold out
Inspire Advisors, LLC0$00.00%−37,698−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−21,131−100.0%Sold out
Corton Capital Inc.0$00.00%−18,409−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−14,026−100.0%Sold out
Axq Capital, LP0$00.00%−12,943−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−11,929−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−11,039−100.0%Sold out
Denali Advisors LLC0$00.00%−9,000−100.0%Sold out
CWM, LLC0$00.00%−413−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−350−100.0%Sold out
GWM Advisors LLC0$00.00%−215−100.0%Sold out
Glassman Wealth Services0$00.00%−183−100.0%Sold out